Weight Loss
Do Medical Weight Loss Clinics Work? What Research Shows
Updated October 31, 2026 · 7 min read
Medical weight loss clinics can work when they follow the research: a reduced-calorie eating plan, more activity, regular support and, when it fits, medication. The National Institutes of Health reports that adults who add a prescription medication to a lifestyle program lose an average of 3% to 12% more of their starting weight after a year.
At Padgett Medical Center, medical weight loss in Ocala is medically supervised, in person or by telehealth. The main options are weekly injections of personalized compounded semaglutide or personalized compounded tirzepatide, or phentermine, a daily pill.
What does research say about structured weight loss programs?
Structure and support make a measurable difference. In the Diabetes Prevention Program, a large federally funded study of 3,234 adults with above-normal blood sugar, one group took a placebo, a pill without medicine, and got standard advice: written information and one 20- to 30-minute session a year. Another got an intensive lifestyle program: 16 one-on-one lessons on diet, exercise and behavior in the first 24 weeks, then regular follow-up sessions.
The program aimed for a loss of at least 7% of body weight and at least 150 minutes a week of moderate activity, such as brisk walking. Its participants lost about 12 pounds on average, while the placebo group's weight barely changed. Over about three years, the lifestyle group developed type 2 diabetes at a rate 58% lower than the placebo group. The placebo group had also been encouraged to lose weight and be more active, so the intensive program made the difference.
Look AHEAD, another federally funded study, tested an intensive lifestyle program in adults with type 2 diabetes and overweight or obesity. It showed that they can lose weight and keep some of it off, says the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Why most diets fail explains why going it alone is so hard.
How much weight loss actually makes a difference?
Often less than you might think: 5% to 10% of your starting weight. NIDDK says a loss in that range may help lower blood sugar, blood pressure and triglycerides, a type of fat in the blood.
A Look AHEAD analysis of its 5,145 participants found that after one year, those who lost 5% to just under 10% of their weight had about 3.5 times the odds of a half-point drop in A1c, a measure of average blood sugar, compared with those whose weight held steady. They were also more likely to see meaningful improvements in blood pressure, triglycerides and HDL, the "good" cholesterol, and those who lost 10% to 15% had even greater odds on most of these.
NIDDK says experts recommend an initial goal of 5% to 10% of your starting weight within 6 months. Setting weight loss goals that stick covers how to set one you can keep.
How much more do weight loss medications add?
It depends on the medication and the person, but on average the extra loss over a lifestyle program alone is 3% to 12% of starting weight after a year, NIDDK says. It adds that with some medications, more than half of study participants lose 10% or more of their starting weight.
Two large studies of FDA-approved GLP-1 (glucagon-like peptide-1) medications, which mimic hormones that help regulate appetite, show how wide the gap can be. In STEP 1, a study of FDA-approved semaglutide, 1,961 adults with overweight or obesity and without diabetes all had a lifestyle program, plus a weekly injection of the medication or a placebo. After 68 weeks, the medication group had lost 14.9% of their weight on average, versus 2.4% with placebo, and 86.4% had lost at least 5%, versus 31.5%.
In SURMOUNT-1, a study of FDA-approved tirzepatide, 2,539 similar adults took one of three doses or a placebo for 72 weeks. Average weight loss ranged from 15.0% to 20.9%, depending on the dose, versus 3.1% with placebo, and 85% to 91% lost at least 5%, versus 35%. Those figures describe FDA-approved products, not Padgett's personalized compounded medications, and your own results may differ.
Phentermine, an FDA-approved generic appetite suppressant pill labeled for short-term use alongside a reduced-calorie diet, exercise and behavior change, is Padgett's non-GLP-1 option; NIDDK notes the FDA approved it for only a few weeks of use. See phentermine weight loss in Ocala or phentermine vs. personalized compounded semaglutide.
Why does medical supervision matter?
Because these medicines are not right for everyone, and their side effects need watching. NIDDK warns never to take a weight loss medication only to improve how you look, since in some cases the side effects may outweigh the benefits. It also says never to take one during pregnancy or while planning a pregnancy, and to tell your provider about every medicine and supplement you take.
Stomach problems were the most common side effects in both GLP-1 studies. In STEP 1, nausea and diarrhea led the list; they were usually mild to moderate and faded with time, yet 4.5% of people on the medication stopped it because of stomach problems, versus 0.8% on placebo. In SURMOUNT-1, most stomach side effects were mild to moderate and came mainly while the dose was being raised.
That is one reason a provider sets and adjusts your dose with you. Report side effects, and never change your dose yourself. For practical tips, see managing GLP-1 side effects.
What results are realistic, and how long do they take?
Expect a range, not a promise: even in the two GLP-1 studies, not everyone on the medication reached a 5% loss. NIDDK says most weight loss takes place within the first 6 months of starting a medication, so expect the pace to slow after that; our article on a weight loss plateau on a GLP-1 explains what a slowdown can mean.
NIDDK calls obesity a chronic disease and says you may need to keep your new eating and activity habits for years, or even a lifetime, to maintain a healthier weight. Our article on stopping a GLP-1 medication covers what the research shows; stopping is a decision to make with your provider.
What makes a weight loss program work?
NIDDK lists five features to look for in any program: realistic goals, a reduced-calorie eating plan, an activity plan, guidance and support, and a plan for keeping the weight off. It says the eating plan should be backed by science and fit your health, culture and preferences, so you can stick with it.
Support means counseling on goals and setbacks, plus regular feedback in person, by phone or online. Before you join, NIDDK suggests asking what training the staff have, how much weight the average person loses and how long they keep it off, and the total cost from start to finish, including extras such as visit fees, supplements or medical tests.
Which weight loss programs should you avoid?
Skip any program that promises too much. NIDDK's warning signs include claims that you can lose weight without diet or exercise, eat as much as you want of your favorite foods, lose 30 pounds in 30 days or lose weight from one part of your body. It also flags very small print, asterisks and footnotes, and before-and-after photos or personal endorsements that seem too good to be true.
How does medical weight loss work at Padgett in Ocala?
Your visits are with Sarah Weir, APRN, an advanced practice registered nurse, at 200 SW 8th St., Suite A, just south of downtown Ocala, or by telehealth anywhere in Florida, as long as you're physically in Florida at the time of the visit. Dr. Jose Diaz, MD, is Padgett's Medical Director.
On personalized compounded semaglutide or personalized compounded tirzepatide, your provider personalizes your dose and adjusts it with you over time, you get clear instructions for your exact medication, and it's shipped to your door in Florida. How we personalize your plan walks through each step.
Pricing is by dose. Personalized compounded semaglutide starts at $149 a month and personalized compounded tirzepatide at $229 a month, at the starting dose; each service page prices the other doses. The monthly price is your medication. Your provider visit is $100 and is free when you start medication at that visit; the only other charge is a $50 no-show fee.
The no-show fee applies if you don't show, or don't cancel or reschedule at least 24 hours ahead, and it can be applied to your next visit. There's no contract, and you don't need insurance; see what personalized compounded semaglutide costs without insurance. Phentermine is priced differently, with the visit, the medication and a B12 injection included; see what phentermine costs in Ocala.
You can book online, and nothing is charged at booking; the clinic holds your visit with a card on file. Booking without a card works too, but the appointment isn't confirmed until staff reach you by phone. Questions first? Padgett offers a free consultation: a free 15-minute phone call with the medical staff; it is not a visit with the provider and nothing is prescribed on it.
Book a weight loss visit at the Ocala clinic or by telehealth, or call (352) 369-0104, Monday to Friday, 9:00 AM to 5:00 PM.
Personalized compounded semaglutide and personalized compounded tirzepatide are compounded drugs that have not been approved by the FDA. They have not been reviewed by the FDA for safety, effectiveness, or quality. FDA-approved products containing semaglutide and tirzepatide are available. Individual results vary.
This article is educational and is not medical advice. Talk with a licensed provider about your own health, medications and treatment options.
Pending medical review. This article is educational and is not medical advice. Never start, stop, split or change the timing of a prescription based on something you read online. Your provider decides your dose and your schedule.
Frequently asked questions
Do you need medication, or can a lifestyle program be enough?
A lifestyle program alone may be enough for some people. NIDDK says weight loss medications aren't for everyone with a high BMI, and that you might lose weight with a program that changes your eating and activity habits. If those changes aren't enough, a provider may add medication. At Padgett, your provider decides with you whether medication fits your health.
What happens if a weight loss medication isn't working for you?
Your provider reviews your progress and may change the plan. NIDDK says that if you haven't lost at least 5% of your starting weight after 12 weeks on the full dose, your health care professional will probably advise stopping it, and may suggest a different medication or approach. Don't stop or change a dose on your own.
Can a weight loss program work by telehealth?
Some virtual programs may work, NIDDK says, if they include a good program's key features. It advises looking for weekly sessions tailored to your goals, a trained professional's support, progress tracking and regular feedback, and says researchers are still studying how well they work. Padgett's telehealth visits are with your provider, anywhere in Florida while you're physically in the state.
Can losing weight help with more than blood sugar and blood pressure?
It can. NIDDK says losing weight can also improve other weight-related problems, such as joint pain and sleep apnea, and that in the Look AHEAD study, weight loss brought benefits such as better physical mobility. Mention joint pain or sleep problems at your visit; weight loss and better sleep explains the sleep apnea link.
Does a weight loss program have to include exercise?
Yes, when activity is appropriate for you. NIDDK says a program should include a plan for regular physical activity, with the amount and type set by your health and ability. Activity may not move the scale much by itself, but it has health benefits beyond weight loss and may help you keep off the weight you lose.
Sources
- Choosing a Safe & Successful Weight-loss Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Prescription Medications to Treat Overweight & Obesity, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin, New England Journal of Medicine, 2002 (Knowler and colleagues, Diabetes Prevention Program Research Group), PubMed Central
- Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes, Diabetes Care, 2011 (Wing and colleagues, Look AHEAD Research Group), PubMed
- Once-Weekly Semaglutide in Adults with Overweight or Obesity, New England Journal of Medicine, 2021 (Wilding and colleagues, STEP 1 Study Group; study of the FDA-approved product), PubMed
- Tirzepatide Once Weekly for the Treatment of Obesity, New England Journal of Medicine, 2022 (Jastreboff and colleagues, SURMOUNT-1 Investigators; study of the FDA-approved product), PubMed
